153
Views
27
CrossRef citations to date
0
Altmetric
Review

T-cell immunity generated by recombinant adenovirus vaccines

, , , , &
Pages 347-356 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Angela M Bodles-Brakhop & Ruxandra Draghia-Akli. (2008) DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Expert Review of Vaccines 7:7, pages 1085-1101.
Read now

Articles from other publishers (26)

Tooran Nayeri, Shahabeddin Sarvi, Mahdi Fasihi-Ramandi, Reza Valadan, Hossein Asgarian-Omran, Abolghasem Ajami, Alireza khalilian, Zahra Hosseininejad, Samira Dodangeh, Javad Javidnia & Ahmad Daryani. (2023) Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice. Experimental Parasitology 244, pages 108427.
Crossref
Eliel Nham, Joon Young Song, Ji Yun Noh, Hee Jin Cheong & Woo Joo Kim. (2022) COVID-19 Vaccination in Korea: Past, Present, and the Way Forward. Journal of Korean Medical Science 37:47.
Crossref
Coralie F. Daussy, Noémie Pied & Harald Wodrich. (2021) Understanding Post Entry Sorting of Adenovirus Capsids; A Chance to Change Vaccine Vector Properties. Viruses 13:7, pages 1221.
Crossref
Cyrielle Fougeroux, Louise Turner, Anders Miki Bojesen, Thomas Lavstsen & Peter Johannes Holst. (2019) Modified MHC Class II–Associated Invariant Chain Induces Increased Antibody Responses against Plasmodium falciparum Antigens after Adenoviral Vaccination . The Journal of Immunology 202:8, pages 2320-2331.
Crossref
Masoud Foroutan, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhosein Dalimi & Ogholniaz Jorjani. (2019) Rhoptry antigens as Toxoplasma gondii vaccine target . Clinical and Experimental Vaccine Research 8:1, pages 4.
Crossref
Rong Wang, Aizhang Xu, Xueying Zhang, Jie Wu, Andrew Freywald, Jianqing Xu & Jim Xiang. (2016) Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway. Cellular & Molecular Immunology 14:6, pages 529-545.
Crossref
Xiu-Zhen Li, Xiao-Hu Wang, Li-Jun Xia, Ya-Biao Weng, Jorge A Hernandez, Li-Qing Tu, Lu-Tao Li, Shou-Jun Li & Zi-Guo Yuan. (2015) Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice. BMC Infectious Diseases 15:1.
Crossref
Lisanework E. Ayalew, Pankaj Kumar, Amit Gaba, Niraj Makadiya & Suresh K. Tikoo. (2015) Bovine adenovirus-3 as a vaccine delivery vehicle. Vaccine 33:4, pages 493-499.
Crossref
Amy R. Noe, Diego Espinosa, Xiangming Li, Jordana G. A. Coelho-dos-Reis, Ryota Funakoshi, Steve Giardina, Hongfan Jin, Diane M. Retallack, Ryan Haverstock, Jeffrey R. Allen, Thomas S. Vedvick, Christopher B. Fox, Steven G. Reed, Ramses Ayala, Brian Roberts, Scott B. Winram, John Sacci, Moriya Tsuji, Fidel Zavala & Gabriel M. Gutierrez. (2014) A Full-Length Plasmodium falciparum Recombinant Circumsporozoite Protein Expressed by Pseudomonas fluorescens Platform as a Malaria Vaccine Candidate. PLoS ONE 9:9, pages e107764.
Crossref
Beatrice O. Ondondo. (2014) The influence of delivery vectors on HIV vaccine efficacy. Frontiers in Microbiology 5.
Crossref
Ronald G. Crystal. (2014) Adenovirus: The First Effective In Vivo Gene Delivery Vector . Human Gene Therapy 25:1, pages 3-11.
Crossref
Érica Araújo Mendes, Flavio G. Fonseca, Bárbara M. Casério, Janaína P. Colina, Ricardo Tostes Gazzinelli & Braulia C. Caetano. (2013) Recombinant Vaccines against T. gondii: Comparison between Homologous and Heterologous Vaccination Protocols Using Two Viral Vectors Expressing SAG1. PLoS ONE 8:5, pages e63201.
Crossref
Beatrice Bolinger, Stuart Sims, Geraldine O’Hara, Catherine de Lara, Elma Tchilian, Sonja Firner, Daniel Engeler, Burkhard Ludewig & Paul Klenerman. (2013) A New Model for CD8+ T Cell Memory Inflation Based upon a Recombinant Adenoviral Vector. The Journal of Immunology 190:8, pages 4162-4174.
Crossref
Byoung-Shik Shim, Konrad Stadler, Huan Huu Nguyen, Cheol-Heui Yun, Dong Wook Kim, Jun Chang, Cecil Czerkinsky & Man Ki Song. (2012) Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain. Virology Journal 9:1.
Crossref
Bangxing Hong, Sung-Hyung Lee, Xiao-Tong Song, Lindsey Jones, Keigo Machida, Xue F. Huang & Si-Yi Chen. (2012) A Super TLR Agonist to Improve Efficacy of Dendritic Cell Vaccine in Induction of Anti-HCV Immunity. PLoS ONE 7:11, pages e48614.
Crossref
Jin Huk Choi, Joe Dekker, Stephen C. Schafer, Jobby John, Craig E. Whitfill, Christopher S. Petty, Eid E. Haddad & Maria A. Croyle. (2012) Optimized Adenovirus-Antibody Complexes Stimulate Strong Cellular and Humoral Immune Responses against an Encoded Antigen in Naïve Mice and Those with Preexisting Immunity. Clinical and Vaccine Immunology 19:1, pages 84-95.
Crossref
A. Sistigu, L. Bracci, M. Valentini, E. Proietti, R. Bona, D.R.M. Negri, A.R. Ciccaglione, E. Tritarelli, R. Nisini, M. Equestre, A. Costantino, C. Marcantonio, S.M. Santini, C. Lapenta, S. Donati, P. Tataseo, M. Miceli, A. Cara & M. Federico. (2011) Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells. Vaccine 29:18, pages 3465-3475.
Crossref
Anja Krause & Stefan Worgall. (2011) Delivery of antigens by viral vectors for vaccination. Therapeutic Delivery 2:1, pages 51-70.
Crossref
Lisa M. Runco & J. Robert Coleman. (2011) Harnessing DNA Synthesis to Develop Rapid Responses to Emerging and Pandemic Pathogens. Journal of Pathogens 2011, pages 1-7.
Crossref
Catherine Tang, Pamela J. Russell, Rosetta Martiniello-Wilks, John E. J. Rasko & Aparajita Khatri. (2010) Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?. Stem Cells 28:9, pages 1686-1702.
Crossref
Maurizio Federico. (2010) Virus-like particles show promise as candidates for new vaccine strategies. Future Virology 5:4, pages 371-374.
Crossref
Jonathan D. Finn, Jennifer Bassett, James B. Millar, Natalie Grinshtein, Teng Chih Yang, Robin Parsons, Carole Evelegh, Yonghong Wan, Robin J. Parks & Jonathan L. Bramson. (2009) Persistence of Transgene Expression Influences CD8 + T-Cell Expansion and Maintenance following Immunization with Recombinant Adenovirus . Journal of Virology 83:23, pages 12027-12036.
Crossref
Paola Di Bonito, Felicia Grasso, Stefania Mochi, Linda Petrone, Emanuele Fanales-Belasio, Arianna Mei, Armando Cesolini, Giuseppe Laconi, Heinke Conrad, Helga Bernhard, Claudia J. Dembek, Antonio Cosma, Stefano M. Santini, Caterina Lapenta, Simona Donati, Claudia Muratori, Colomba Giorgi & Maurizio Federico. (2009) Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein. Virology 395:1, pages 45-55.
Crossref
Sergey S Seregin, Daniel M Appledorn, Aaron J McBride, Nathaniel J Schuldt, Yasser A Aldhamen, Tyler Voss, Junping Wei, Matthew Bujold, William Nance, Sarah Godbehere & Andrea Amalfitano. (2009) Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy. Molecular Therapy 17:4, pages 685-696.
Crossref
Martine Bruley Rosset, Antoine Sacquin, Sylvie Lecollinet, Thomas Chaigneau, Micheline Adam, François Crespeau & Marc Eloit. (2009) Dendritic Cell-Mediated-Immunization with Xenogenic PrP and Adenoviral Vectors Breaks Tolerance and Prolongs Mice Survival against Experimental Scrapie. PLoS ONE 4:3, pages e4917.
Crossref
Reinhold Schirmbeck, Jörg Reimann, Stefan Kochanek & Florian Kreppel. (2008) The Immunogenicity of Adenovirus Vectors Limits the Multispecificity of CD8 T-cell Responses to Vector-encoded Transgenic Antigens. Molecular Therapy 16:9, pages 1609-1616.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.